Fiche publication
Date publication
septembre 2018
Journal
BMC medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Covic A, Genovesi S, Rossignol P, Kalra PA, Ortiz A, Banach M, Burlacu A
Lien Pubmed
Résumé
The choice of the most appropriate antithrombotic regimen that balances ischemic and bleeding risks was addressed by the August 2017 European Society of Cardiologists (ESC)/European Association for Cardio-Thoracic Surgery Focused Update recommendations, which propose new evaluation scores and protocols for patients requiring a coronary stent or patients with an acute coronary syndrome, atrial fibrillation, or a high bleeding risk and indication for oral anticoagulation therapy.
Mots clés
Anticoagulation, Antithrombotics, Bleeding, Cardiovascular disease, Chronic kidney disease, Ischemic heart disease, Risk score
Référence
BMC Med. 2018 Sep 19;16(1):158
